Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of age
Faller, Douglas V.
Pinkert, Carl A.
Irwin, Michael H.
Moos, Walter H.
MetadataShow full item record
Citation (published version)Kosta Steliou, Douglas V Faller, Carl A Pinkert, Michael H Irwin, Walter H Moos. 2015. "Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of age." Drug Development Research, Volume 76, Issue 4, pp. 167 - 175. https://doi.org/10.1002/ddr.21258
Given nuclear-power-plant incidents such as the 2011 Japanese Fukushima-Daiichi disaster, an urgent need for effective medicines to protect against and treat the harmful biological effects of radiation is evident. To address such a challenge, we describe potential strategies herein including mitochondrial and epigenetic-driven methods using lipoic and butyric acid ester conjugates of carnitine. The antioxidant and other therapeutically beneficial properties of this class of agents may protect against ionizing radiation and resultant mitochondrial dysfunction. Recent studies of the compounds described herein reveal the potential–although further research and development is required to prove the effectiveness of this approach–to provide field-ready radiation-protective drugs.
Please note: this work is permanently embargoed in OpenBU. No public access is forecasted for this item. To request private access, please click on the locked Download file link and fill out the appropriate web form.
Showing items related by title, author, creator and subject.
Hafften, Nicholas (2015)Research into the gut microbiome has revealed the widespread influence that microbial species have on their host. Host genetics and environmental factors influence the abundance and diversity of the bacterial species living ...
Yu, Bea; Dukovski, Ilija; Kong, David; Bobrow, Johanna; Ostrinskaya, Alla; Segre, Daniel; Thorsen, Todd (2018-10-16)Understanding how production of specific metabolites by gut microbes is modulated by interactions with surrounding species and by environmental nutrient availability is an important open challenge in microbiome research. ...
Moos, Walter H.; Maneta, Eleni; Pinkert, Carl A.; Irwin, Michael H.; Hoffman, Michelle E.; Faller, Douglas V.; Steliou, Kosta (John Wiley & Sons, Inc., 2016-03-01)Neuropsychiatric disorders are a heterogeneous group of conditions that often share underlying mitochondrial dysfunction and biological pathways implicated in their pathogenesis, progression, and treatment. To date, these ...